Keywords
Last Name
Institution

Ernest Ramsay Camp

Title
InstitutionMedical University of South Carolina
DepartmentSurgery
AddressP.O. Box MSC 295
BM 241
Thurmond Gazes - 30 Courtenay Drive
Phone843-876-4848
Fax843-876-3046
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. E. Ramsay Camp, M.D., FACS is an Associate Professor of Surgery, Section of Surgical Oncology at the Medical University of South Carolina. He completed his undergraduate degree at Davidson College and his medical degree at the Medical University of South Carolina. He performed his General Surgery training at the Shand's Hospital at the University of Florida and went on to complete a Surgical Oncology Fellowship at the University of Texas M.D. Anderson Cancer Center.


    His clinical and research interests focus on gastrointestinal malignancies including pancreatic, rectal, and gastric cancer as well as melanoma and sarcoma. Since becoming a faculty member in 2007, he has helped develop the Melanoma and Skin Cancer Program and currently serves as the program leader. Dr. Camp has an active research laboratory with a focus on mechanisms of chemotherapy and radiation resistance. He is a Fellow of the American College of Surgeons and a member of various oncology societies including the Society of Surgical Oncology, American Society of Clinical Oncology, American Association of Cancer Research, National Surgical Adjuvant Breast and Bowel Project (NSABP), Southwest Oncology Group (SWOG), and the American College of Surgeons Oncology Group (ACOSOG).

    Collapse keywords
    Cancer/Gastrointestinal, Cancer

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anderson BJ, Wahlquist AE, Hill EG, Marshall DT, Kimchi ET, Staveley O'Carroll KF, Camp ER. The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patients. Int J Surg. 2016 Sep; 33 Pt A:8-12. PMID: 27432024.
      View in: PubMed
    2. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016 May 01; 122(9):1349-69. PMID: 26799932.
      View in: PubMed
    3. Little EC, Camp ER, Wang C, Watson PM, Watson DK, Cole DJ. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016 Jan 11; 5:e182. PMID: 26751936.
      View in: PubMed
    4. Dowden JE, Kimchi ET, Camp ER, Morgan KA, Adams DB, Staveley-O'Carroll KF. Central Pancreatectomy with Pancreaticogastrostomy for the Treatment of a Solid-pseudopapillary Neoplasm. Am Surg. 2015 Nov; 81(11):E383-4. PMID: 26672573.
      View in: PubMed
    5. Dowden JE, Staveley-O'Carroll KF, Kimchi ET, Camp ER, Morgan KA, Adams DB. Ampullary Gangliocytic Paraganglioma with Lymph Node Metastasis. Am Surg. 2015 Nov; 81(11):E359-60. PMID: 26672564.
      View in: PubMed
    6. Hardie AD, Picard MM, Camp ER, Perry JD, Suranyi P, De Cecco CN, Schoepf UJ, Wichmann JL. Application of an Advanced Image-Based Virtual Monoenergetic Reconstruction of Dual Source Dual-Energy CT Data at Low keV Increases Image Quality for Routine Pancreas Imaging. J Comput Assist Tomogr. 2015 Sep-Oct; 39(5):716-20. PMID: 26196343.
      View in: PubMed
    7. Camp ER, Ellis LM. CCR 20th Anniversary Commentary: RAS as a Biomarker for EGFR--Targeted Therapy for Colorectal Cancer-From Concept to Practice. Clin Cancer Res. 2015 Aug 15; 21(16):3578-80. PMID: 26275951.
      View in: PubMed
    8. Anderson BJ, Hill EG, Sweeney RE, Wahlquist AE, Marshall DT, Staveley O'Carroll KF, Cole DJ, Camp ER. The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9. PMID: 25975325.
      View in: PubMed
    9. Findlay VJ, Wang C, Nogueira LM, Hurst K, Quirk D, Ethier SP, Staveley O'Carroll KF, Watson DK, Camp ER. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther. 2014 Nov; 13(11):2713-26. PMID: 25249558.
      View in: PubMed
    10. Findlay VJ, Wang C, Watson DK, Camp ER. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer. Cancer Gene Ther. 2014 May; 21(5):181-7. PMID: 24787239.
      View in: PubMed
    11. Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, Cole DJ, Montero AJ, Hoffman BJ, Romagnuolo J, Orwat KP, Marshall DT. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44. PMID: 24606850.
      View in: PubMed
    12. Fritsch VA, Camp ER, Lentsch EJ. Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival. Head Neck. 2014 Apr; 36(4):571-9. PMID: 24446426.
      View in: PubMed
    13. Findlay VJ, Moretz RE, Wang C, Vaena SG, Bandurraga SG, Ashenafi M, Marshall DT, Watson DK, Camp ER. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog. 2014 Feb; 53 Suppl 1:E130-9. PMID: 23996472.
      View in: PubMed
    14. Johannesmeyer D, Smith V, Cole DJ, Esnaola NF, Camp ER. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95. PMID: 23806824.
      View in: PubMed
    15. Camp ER, Wang C, Little EC, Watson PM, Pirollo KF, Rait A, Cole DJ, Chang EH, Watson DK. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8. PMID: 23470564.
      View in: PubMed
    16. Selander C, Pullatt R, Esnaola N, Camp ER. Pneumatosis intestinalis after open jejunostomy tube placement. Am Surg. 2013 Feb; 79(2):E73-5. PMID: 23336639.
      View in: PubMed
    17. Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, Larue AC, Turner DP, Findlay VJ. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. Breast Cancer Res. 2013; 15(4):R70. PMID: 23971998.
      View in: PubMed
    18. Yang Y, Mauldin PD, Ebeling M, Hulsey TC, Liu B, Thomas MB, Camp ER, Esnaola NF. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. 2013 Apr 15; 119(8):1512-20. PMID: 23280333.
      View in: PubMed
    19. Wright S, Armeson K, Hill EG, Streck C, Leddy L, Cole D, Esnaola N, Camp ER. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012 Oct; 204(4):428-33. PMID: 22578407.
      View in: PubMed
    20. Smith VA, Camp ER, Lentsch EJ. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. Laryngoscope. 2012 Jun; 122(6):1283-90. PMID: 22522673.
      View in: PubMed
    21. Little EC, Wang C, Watson PM, Watson DK, Cole DJ, Camp ER. Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. J Surg Res. 2012 Aug; 176(2):359-66. PMID: 22221605.
      View in: PubMed
    22. Camp ER, Findlay VJ, Vaena SG, Walsh J, Lewin DN, Turner DP, Watson DK. Slug expression enhances tumor formation in a noninvasive rectal cancer model. J Surg Res. 2011 Sep; 170(1):56-63. PMID: 21470622.
      View in: PubMed
    23. Fan F, Gray MJ, Dallas NA, Yang AD, Van Buren G, Camp ER, Ellis LM. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Mol Cancer Ther. 2008 Sep; 7(9):3064-70. PMID: 18790786.
      View in: PubMed
    24. Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, Cormier JN. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol. 2008 Mar; 19(3):577-82. PMID: 18024857.
      View in: PubMed
    25. Van Buren G, Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Fan F, Camp ER, Yao JC, Ellis LM. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res. 2007 Aug 15; 13(16):4704-12. PMID: 17699847.
      View in: PubMed
    26. Bauer TW, Fan F, Liu W, Camp ER, Yang A, Somcio RJ, Bucana CD, Singh R, Ellis LM. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Ann Surg Oncol. 2007 Oct; 14(10):2838-46. PMID: 17653802.
      View in: PubMed
    27. Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer. 2007 Mar 15; 109(6):1030-9. PMID: 17311308.
      View in: PubMed
    28. Van Buren G, Camp ER, Yang AD, Gray MJ, Fan F, Somcio R, Ellis LM. The role of nitric oxide in mediating tumour blood flow. Expert Opin Ther Targets. 2006 Oct; 10(5):689-701. PMID: 16981826.
      View in: PubMed
    29. Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 1):4147-53. PMID: 16857785.
      View in: PubMed
    30. Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, Ellis LM. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2628-33. PMID: 16638876.
      View in: PubMed
    31. Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 2006 Jan 01; 66(1):46-51. PMID: 16397214.
      View in: PubMed
    32. Camp ER, McAuliffe PF, Gilroy JS, Morris CG, Lind DS, Mendenhall NP, Copeland EM. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg. 2005 Dec; 201(6):855-61. PMID: 16310688.
      View in: PubMed
    33. Yang AD, Bauer TW, Camp ER, Somcio R, Liu W, Fan F, Ellis LM. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy. Cancer. 2005 Apr 15; 103(8):1561-70. PMID: 15754332.
      View in: PubMed
    34. Camp ER, Liu W, Fan F, Yang A, Somcio R, Ellis LM. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann Surg Oncol. 2005 Apr; 12(4):273-81. PMID: 15827676.
      View in: PubMed
    35. Camp ER, Summy J, Bauer TW, Liu W, Gallick GE, Ellis LM. Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor. Clin Cancer Res. 2005 Jan 01; 11(1):397-405. PMID: 15671571.
      View in: PubMed
    36. Camp ER, Hochwald SN, Liu C. FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. J Surg Oncol. 2004 Sep 15; 87(4):187-90. PMID: 15334634.
      View in: PubMed
    37. Camp ER, Li J, Minnich DJ, Brank A, Moldawer LL, MacKay SL, Hochwald SN. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer. J Am Coll Surg. 2004 Aug; 199(2):249-58. PMID: 15275881.
      View in: PubMed
    38. Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F, Moldawer LL, Camp ER, MacKay SL. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res. 2004 Aug; 120(2):178-88. PMID: 15234211.
      View in: PubMed
    39. Camp ER, Cendan JC, Feezor R, Lind DS, Wilkinson E, Copeland EM. The hottest sentinel lymph node is not always the positive node. Am Surg. 2004 Jun; 70(6):475-8; discussion 478. PMID: 15212397.
      View in: PubMed
    40. Camp ER, Vogel SB. Blind Whipple resections for periampullary and pancreatic lesions. Am Surg. 2004 Jan; 70(1):6-10; discussion 11-2. PMID: 14964538.
      View in: PubMed
    41. Schell SR, Camp ER, Caridi JG, Hawkins IF. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg. 2002 Sep-Oct; 6(5):664-70. PMID: 12399054.
      View in: PubMed
    42. Smith MD, Camp E, James H, Kelley HG. Pediatric seat belt injuries. Am Surg. 1997 Mar; 63(3):294-8. PMID: 9036903.
      View in: PubMed
    43. Camp E. Inflammatory carcinoma of the breast: the case for conservatism. Am J Surg. 1976 May; 131(5):583-6. PMID: 818911.
      View in: PubMed
    Camp's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _